https://leo-pharma.it/news/leo-pharma-e-morphosys-estendono-la-loro-alleanza-strategica/ 2026-06-18T11:09:02+00:00 https://leo-pharma.it/news/tinzaparina-sodica-disponibile-in-italia-per-prevenire-e-curare-il-tromboembolismo-venoso/ 2026-06-18T11:12:53+00:00 https://leo-pharma.it/news/segrate-leo-pharma-manufacturing-italy-dona-un-velobus-alla-citta/ 2026-06-18T11:13:54+00:00 https://leo-pharma.it/wp-content/uploads/sites/6/2026/06/news.jpg?w=624 https://leo-pharma.it/news/psoriasi-moderata-grave-disponibile-in-italia-brodalumab-una-pelle-libera-da-lesioni/ 2026-06-18T11:14:39+00:00 https://leo-pharma.it/news/nuovi-dati-dimostrano-che-brodalumab-di-leo-pharma-garantisce-maggiori-probabilita/ 2026-06-18T11:15:35+00:00 https://leo-pharma.it/news/leo-pharma-spa-entra-a-far-parte-di-farmindustria/ 2026-06-18T11:16:17+00:00 https://leo-pharma.it/news/leo-pharma-sottoscritto-accordo-di-licenza-per-il-farmaco-fb825/ 2026-06-18T11:16:53+00:00 https://leo-pharma.it/news/leo-pharma-riceve-il-parere-positivo-del-chmp-su-tralokinumab-per-il-trattamento/ 2026-06-18T11:17:50+00:00 https://leo-pharma.it/news/leo-pharma-consegna-a-domicilio-del-farmaco-biologico-per-i-pazienti/ 2026-06-18T11:21:04+00:00 https://leo-pharma.it/wp-content/uploads/sites/6/2026/06/news3.jpg?w=624 https://leo-pharma.it/news/leo-pharma-conclusa-acquisizione-dei-farmaci-dermatologici-di-bayer-soggetti-a-prescrizione-e/ 2026-06-18T11:22:01+00:00 https://leo-pharma.it/news/leo-pharma-avvia-il-primo-trial-clinico-di-fase-3-con-delgocitinib/ 2026-06-18T11:23:53+00:00 https://leo-pharma.it/news/leo-pharma-annuncia-l-approvazione-da-parte-della-commissione-europea-di-tralokinumab/ 2026-06-18T11:26:00+00:00 https://leo-pharma.it/news/eadv-2020-presentati-i-dati-di-tralokinumab-relativi-alla-sicurezza-2/ 2026-06-18T11:28:34+00:00 https://leo-pharma.it/news/dermatologicamente-progetto-di-supporto-psicologico-a-distanza/ 2026-06-18T11:29:22+00:00 https://leo-pharma.it/wp-content/uploads/sites/6/2026/06/imgi_8_news2.jpg?w=624 https://leo-pharma.it/news/prendi-in-mano-la-tua-vita-la-nuova-campagna-leo-pharma-di-sensibilizzazione/ 2026-06-18T11:31:46+00:00 https://leo-pharma.it/wp-content/uploads/sites/6/2026/06/imgi_8_article-pic-10022026.jpg?w=1024 https://leo-pharma.it/news/leo-pharma-italia-ha-ottenuto-la-certificazione-per-la-parita-di-genere/ 2026-06-18T11:32:46+00:00 https://leo-pharma.it/news/leo-pharma-finalizza-lacquisizione-dei-key-asset-di-timber-pharmaceuticals/ 2026-06-18T11:33:18+00:00 https://leo-pharma.it/news/leo-pharma-consegna-a-domicilio-del-farmaco-biologico-per-i-pazienti-con-psoriasi/ 2026-06-18T11:33:45+00:00 https://leo-pharma.it/news/dermatite-atopica-disponibile-in-italia-il-trattamento-con-anticorpo-monoclonale-tralokinumab-anche-per-adolescenti/ 2026-06-18T11:35:52+00:00 https://leo-pharma.it/news/leo-pharma-acquisisce-i-diritti-per-lo-sviluppo-e-la-commercial/ 2026-06-25T12:43:46+00:00 https://leo-pharma.it/news/leo-pharma-avvia-studio-head-to-head-per-la-valutazione-di-brodalumab-vs/ 2026-06-25T12:44:13+00:00 https://leo-pharma.it/news/al-virtual-congress-eadv-2021-leo-pharma-presenta/ 2026-06-25T12:45:49+00:00 https://leo-pharma.it/news/leo-pharma-e-portal-instruments-annunciano-una-collaborazione-per-lo-sviluppo-di-un/ 2026-06-26T13:47:38+00:00 https://leo-pharma.it/news/la-commissione-europea-approva-delgocitinib-di-leo-pharma-per-il-trattamento-degli-adulti/ 2026-06-26T13:56:46+00:00 https://leo-pharma.it/news/con-una-crescita-del-7-nel-2019-laumento-dei-margini-e-il-successo-della-pipeline/ 2026-06-26T13:58:28+00:00 https://leo-pharma.it/news/i-risultati-positivi-di-uno-studio-di-fase-2b-per-defi/ 2026-06-26T13:59:19+00:00 https://leo-pharma.it/news/leo-pharma-inaugura-il-sito-produttivo-di-segrate/ 2026-06-29T12:05:51+00:00